• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白藜芦醇通过抑制c-Myc/miR-17通路促进乳腺癌细胞中MICA/B的表达及自然杀伤细胞的裂解作用。

Resveratrol promotes MICA/B expression and natural killer cell lysis of breast cancer cells by suppressing c-Myc/miR-17 pathway.

作者信息

Pan Jie, Shen Jiaying, Si Wengong, Du Chengyong, Chen Danni, Xu Liang, Yao Minya, Fu Peifen, Fan Weimin

机构信息

Program of Innovative Cancer Therapeutics, Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, Zhejiang Province, Hangzhou 310003, China.

Breast Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Zhejiang Province, Hangzhou 310003, China.

出版信息

Oncotarget. 2017 Jul 22;8(39):65743-65758. doi: 10.18632/oncotarget.19445. eCollection 2017 Sep 12.

DOI:10.18632/oncotarget.19445
PMID:29029468
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5630368/
Abstract

Major histocompatibility complex class I chain-related proteins A and B (MICA and MICB) are important ligands for recognition of tumor cells by immune effector cells. Here, we report that resveratrol upregulated the protein and mRNA expression of MICA and MICB in breast cancer cells, which in turn promoted breast cancer cell lysis by natural killer (NK) cells and . Antibodies against NK group 2 member D blocked this effect. The 3'-untranslated regions of and were found to be direct binding targets of miR-17. MICA and MICB expression increased or decreased in breast cancer cells transfected with a miR-17 inhibitor or mimic, respectively. overexpression/knockdown increased/decreased transcription of the cluster host gene. Resveratrol suppressed c-Myc expression, which inhibited the transcription of cluster, thereby downregulating miR-17. MiR-17 expression correlated inversely with and expression and overall survival in two sets of breast cancer specimens. Resveratrol thus upregulates MICA and MICB by suppressing the c-Myc/miR-17 pathway in breast cancer cells, and increases the cytolysis of breast cancer cells by NK cells. This suggests resveratrol has the potential to promote antitumor immune responses in breast cancer patients.

摘要

主要组织相容性复合体I类链相关蛋白A和B(MICA和MICB)是免疫效应细胞识别肿瘤细胞的重要配体。在此,我们报告白藜芦醇上调乳腺癌细胞中MICA和MICB的蛋白和mRNA表达,进而促进自然杀伤(NK)细胞对乳腺癌细胞的裂解,抗NK组2成员D抗体可阻断此效应。发现MICA和MICB的3'非翻译区是miR - 17的直接结合靶点。分别用miR - 17抑制剂或模拟物转染的乳腺癌细胞中,MICA和MICB表达增加或减少。miR - 17过表达/敲低分别增加/减少了MICA和MICB基因簇宿主基因的转录。白藜芦醇抑制c - Myc表达,从而抑制MICA和MICB基因簇的转录,进而下调miR - 17。在两组乳腺癌标本中,miR - 17表达与MICA和MICB表达及总生存期呈负相关。因此,白藜芦醇通过抑制乳腺癌细胞中的c - Myc/miR - 17途径上调MICA和MICB,并增加NK细胞对乳腺癌细胞的细胞溶解作用。这表明白藜芦醇具有促进乳腺癌患者抗肿瘤免疫反应的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a420/5630368/f702457217f6/oncotarget-08-65743-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a420/5630368/0575a5b7c1cc/oncotarget-08-65743-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a420/5630368/3e71e1e5c157/oncotarget-08-65743-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a420/5630368/66dba5e85a94/oncotarget-08-65743-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a420/5630368/a7b1c1a51d46/oncotarget-08-65743-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a420/5630368/44f791e8e41c/oncotarget-08-65743-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a420/5630368/1e2c5cdc6a6b/oncotarget-08-65743-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a420/5630368/f702457217f6/oncotarget-08-65743-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a420/5630368/0575a5b7c1cc/oncotarget-08-65743-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a420/5630368/3e71e1e5c157/oncotarget-08-65743-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a420/5630368/66dba5e85a94/oncotarget-08-65743-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a420/5630368/a7b1c1a51d46/oncotarget-08-65743-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a420/5630368/44f791e8e41c/oncotarget-08-65743-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a420/5630368/1e2c5cdc6a6b/oncotarget-08-65743-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a420/5630368/f702457217f6/oncotarget-08-65743-g007.jpg

相似文献

1
Resveratrol promotes MICA/B expression and natural killer cell lysis of breast cancer cells by suppressing c-Myc/miR-17 pathway.白藜芦醇通过抑制c-Myc/miR-17通路促进乳腺癌细胞中MICA/B的表达及自然杀伤细胞的裂解作用。
Oncotarget. 2017 Jul 22;8(39):65743-65758. doi: 10.18632/oncotarget.19445. eCollection 2017 Sep 12.
2
Upregulated expression of NKG2D and its ligands give potential therapeutic targets for patients with thymoma.NKG2D 及其配体的上调表达为胸腺瘤患者提供了潜在的治疗靶点。
Cancer Gene Ther. 2015 Jul;22(7):368-74. doi: 10.1038/cgt.2015.29. Epub 2015 Jun 26.
3
NZ28-induced inhibition of HSF1, SP1 and NF-κB triggers the loss of the natural killer cell-activating ligands MICA/B on human tumor cells.NZ28诱导的HSF1、SP1和NF-κB抑制引发人肿瘤细胞上自然杀伤细胞激活配体MICA/B的丧失。
Cancer Immunol Immunother. 2015 May;64(5):599-608. doi: 10.1007/s00262-015-1665-9. Epub 2015 Feb 18.
4
Diversity and characterization of polymorphic 5' promoter haplotypes of MICA and MICB genes.MICA和MICB基因多态性5'启动子单倍型的多样性与特征分析
Tissue Antigens. 2014 Sep;84(3):293-303. doi: 10.1111/tan.12400. Epub 2014 Jun 25.
5
HER2/HER3 signaling regulates NK cell-mediated cytotoxicity via MHC class I chain-related molecule A and B expression in human breast cancer cell lines.HER2/HER3 信号通过人乳腺癌细胞系中 MHC Ⅰ类链相关分子 A 和 B 的表达调节 NK 细胞介导的细胞毒性。
J Immunol. 2012 Mar 1;188(5):2136-45. doi: 10.4049/jimmunol.1102237. Epub 2012 Feb 1.
6
[Topoisomerase inhibitor upregulates MICA/B expression in breast cancer cells through ATM/ATR and NF-κB pathway].[拓扑异构酶抑制剂通过ATM/ATR和NF-κB途径上调乳腺癌细胞中MICA/B的表达]
Beijing Da Xue Xue Bao Yi Xue Ban. 2018 Apr 18;50(2):318-325.
7
microRNA-889 is downregulated by histone deacetylase inhibitors and confers resistance to natural killer cytotoxicity in hepatocellular carcinoma cells.微小RNA-889被组蛋白去乙酰化酶抑制剂下调,并赋予肝癌细胞对自然杀伤细胞细胞毒性的抗性。
Cytotechnology. 2018 Apr;70(2):513-521. doi: 10.1007/s10616-017-0108-1. Epub 2017 May 26.
8
Upregulation of NKG2D ligands and enhanced natural killer cell cytotoxicity by hydralazine and valproate.肼屈嗪和丙戊酸上调 NKG2D 配体并增强自然杀伤细胞的细胞毒性。
Int J Oncol. 2011 Dec;39(6):1491-9. doi: 10.3892/ijo.2011.1144. Epub 2011 Jul 26.
9
Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: heterogeneous involvement of the "a disintegrin and metalloproteases" 10 and 17.不同人类肿瘤细胞系中内源性 MHC Ⅰ类相关链分子 A 和 B 的脱落:“解整合素和金属蛋白酶”10 和 17 的异质性参与。
Int J Cancer. 2013 Oct 1;133(7):1557-66. doi: 10.1002/ijc.28174. Epub 2013 Apr 18.
10
MMP9 Promoter Polymorphism (-1562 C/T) Does not Affect the Serum Levels of Soluble MICB and MICA in Breast Cancer.基质金属蛋白酶9启动子多态性(-1562 C/T)不影响乳腺癌患者血清中可溶性MICA和MICB水平
Iran J Immunol. 2016 Mar;13(1):45-53.

引用本文的文献

1
Unlocking the Potential of Nutraceuticals in Cancer Chemotherapy: A Comprehensive Review.释放营养保健品在癌症化疗中的潜力:一篇综述
Cureus. 2025 Aug 4;17(8):e89328. doi: 10.7759/cureus.89328. eCollection 2025 Aug.
2
Phytochemicals in Breast Cancer Prevention and Therapy: Mechanisms, Efficacy, and Future Prospects.植物化学物质在乳腺癌预防与治疗中的作用:作用机制、疗效及未来展望
Curr Issues Mol Biol. 2025 Jul 8;47(7):527. doi: 10.3390/cimb47070527.
3
Resveratrol alters erlotinib pharmacokinetics in rats: application of a rapid HPLC-fluorescence method for quantifying erlotinib in plasma.

本文引用的文献

1
Silencing NKG2D ligand-targeting miRNAs enhances natural killer cell-mediated cytotoxicity in breast cancer.沉默靶向NKG2D配体的微小RNA可增强自然杀伤细胞介导的乳腺癌细胞毒性。
Cell Death Dis. 2017 Apr 6;8(4):e2740. doi: 10.1038/cddis.2017.158.
2
GFRα2 prompts cell growth and chemoresistance through down-regulating tumor suppressor gene PTEN via Mir-17-5p in pancreatic cancer.GFRα2 通过下调肿瘤抑制基因 PTEN 促进胰腺癌细胞生长和化疗耐药,其作用机制与 Mir-17-5p 有关。
Cancer Lett. 2016 Oct 1;380(2):434-441. doi: 10.1016/j.canlet.2016.06.016. Epub 2016 Jul 8.
3
Sirtuin 1-dependent resveratrol cytotoxicity and pro-differentiation activity on breast cancer cells.
白藜芦醇改变大鼠体内厄洛替尼的药代动力学:一种用于定量血浆中厄洛替尼的快速高效液相色谱 - 荧光法的应用。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jul 2. doi: 10.1007/s00210-025-04373-8.
4
Robust convex biclustering with a tuning-free method.一种无需调优方法的稳健凸双聚类
J Appl Stat. 2024 Jun 17;52(2):271-286. doi: 10.1080/02664763.2024.2367143. eCollection 2025.
5
Revolutionizing Cancer Treatment: Recent Advances in Immunotherapy.变革癌症治疗:免疫疗法的最新进展
Biomedicines. 2024 Sep 23;12(9):2158. doi: 10.3390/biomedicines12092158.
6
Oligandrin from (Euphorbiaceae) exhibits anti-breast cancer activity through immune-boosting mechanisms: and study.来自大戟科的寡配体蛋白通过增强免疫机制展现出抗乳腺癌活性:一项[具体研究主体1]和[具体研究主体2]的研究。 (原文中括号部分缺失具体信息)
Heliyon. 2024 Jul 23;10(15):e35000. doi: 10.1016/j.heliyon.2024.e35000. eCollection 2024 Aug 15.
7
Antitumor Effects of Resveratrol Opposing Mechanisms of in Gastric Cancer.白藜芦醇对抗胃癌中作用机制的抗肿瘤作用。
Nutrients. 2024 Jul 4;16(13):2141. doi: 10.3390/nu16132141.
8
Resveratrol in the Treatment of Gynecological Cancer: Mechanisms and Therapeutic Potential.白藜芦醇在妇科癌症治疗中的作用机制及治疗潜力
Curr Med Chem. 2024 May 3. doi: 10.2174/0109298673290941240430171146.
9
MicroRNA-18a prevents senescence of mesenchymal stem cells by targeting CTDSPL.MicroRNA-18a 通过靶向 CTDSPL 防止间充质干细胞衰老。
Aging (Albany NY). 2024 Mar 7;16(5):4904-4919. doi: 10.18632/aging.205642.
10
Resveratrol: Targeting Cancer Stem Cells and ncRNAs to Overcome Cancer Drug Resistance.白藜芦醇:通过靶向肿瘤干细胞和非编码 RNA 克服癌症耐药性。
Curr Mol Med. 2024;24(8):951-961. doi: 10.2174/1566524023666230817102114.
沉默调节蛋白1依赖性白藜芦醇对乳腺癌细胞的细胞毒性和促分化活性。
Arch Toxicol. 2017 Mar;91(3):1261-1278. doi: 10.1007/s00204-016-1784-x. Epub 2016 Jun 29.
4
NKG2D- and T-cell receptor-dependent lysis of malignant glioma cell lines by human γδ T cells: Modulation by temozolomide and A disintegrin and metalloproteases 10 and 17 inhibitors.人γδ T细胞对恶性胶质瘤细胞系的NKG2D和T细胞受体依赖性裂解:替莫唑胺以及解整合素和金属蛋白酶10与17抑制剂的调节作用
Oncoimmunology. 2015 Dec 10;5(4):e1093276. doi: 10.1080/2162402X.2015.1093276. eCollection 2016 Apr.
5
MiR-17-5p regulates cell proliferation and migration by targeting transforming growth factor-β receptor 2 in gastric cancer.微小RNA-17-5p通过靶向胃癌中的转化生长因子-β受体2来调节细胞增殖和迁移。
Oncotarget. 2016 May 31;7(22):33286-96. doi: 10.18632/oncotarget.8946.
6
Resveratrol inhibits cell cycle progression by targeting Aurora kinase A and Polo-like kinase 1 in breast cancer cells.白藜芦醇通过靶向乳腺癌细胞中的极光激酶A和波罗样激酶1来抑制细胞周期进程。
Oncol Rep. 2016 Jun;35(6):3696-704. doi: 10.3892/or.2016.4728. Epub 2016 Apr 4.
7
ANXA1 inhibits miRNA-196a in a negative feedback loop through NF-kB and c-Myc to reduce breast cancer proliferation.膜联蛋白A1通过核因子-κB和c-Myc在负反馈回路中抑制微小RNA-196a,以减少乳腺癌增殖。
Oncotarget. 2016 May 10;7(19):27007-20. doi: 10.18632/oncotarget.8875.
8
miR-17-92 cluster components analysis in Burkitt lymphoma: overexpression of miR-17 is associated with poor prognosis.伯基特淋巴瘤中miR-17-92簇成分分析:miR-17的过表达与预后不良相关。
Ann Hematol. 2016 May;95(6):881-91. doi: 10.1007/s00277-016-2653-7. Epub 2016 Apr 5.
9
Resveratrol inhibits ovarian tumor growth in an in vivo mouse model.白藜芦醇抑制体内小鼠模型中的卵巢肿瘤生长。
Cancer. 2016 Mar 1;122(5):722-9. doi: 10.1002/cncr.29793. Epub 2015 Nov 30.
10
Histone deacetylase inhibitor SAHA epigenetically regulates miR-17-92 cluster and MCM7 to upregulate MICA expression in hepatoma.组蛋白去乙酰化酶抑制剂SAHA通过表观遗传调控miR-17-92簇和MCM7,以上调肝癌中MICA的表达。
Br J Cancer. 2015 Jan 6;112(1):112-21. doi: 10.1038/bjc.2014.547. Epub 2014 Nov 13.